Presenter's Information

Jung-Min Ahn , MD

Country Korea (Republic of)
Specialty Interventional Cardiologist
  1. How I Treated the Case
  2. How Would I Treat the Case
  3. Master's Case 1. Ischemic Cardiomyopathy with Multi-vessel Disease
  4. TAVR for Bicuspid AV: What's Different?
  5. VARIANT-ICD Trial: ICD vs. Medical Therapy Alone in Variant Angina With Aborted SCD
  6. FATE-MAIN Trial: FFR- vs. Angiography-guided Left Main PCI
  7. PREVENT Trial: Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque
  8. 15 Years History of TAVR in Asan Medical Center: Minimalist Intuitive Simple Approaches
  9. Bicuspid TAVR: All the Technical Issues and Data From Asan Medical Center
  10. Synergetic Approach for Discordant Lesions Between FFR and Non-Hyperemic Indexes
  11. The Fate of Deferred Lesions; Insight From the IRIS-FFR Registry
  12. Rule of 5-6-7-8 for Bifurcation PCI: It Is Time to Change in 2024
  13. Left Main AMI with Cardiogenic Shock, How to Rescue?
  14. Choosing Wisely: FFR vs. Anatomy Dilemma in LM PCI and Introduction to FATE-MAIN Trial
  15. Precision in Stent Sizing: Insights from Imaging-Guided LM PCI
  16. TAVR for Bicuspid AV: What’s Different?
  17. Synergetic Approach for Discordant Lesions Between FFR and Hyperemia Free Indexes
  18. ASSURE-DES Trial
  19. 10-Year Extended Follow-up of BEST Trial
  20. Defining Lesion Severity (by Angiography, Physiology & IVUS)
  21. Not to Treat
  22. Optimal MSA for LM Crush Technique: New Criteria Any Difference in Any 2 Stent Technique?
  23. TAVR Techniques in Bicuspid Anatomy – Valve Selection, Sizing, and Positioning
  24. How to Optimize 1st Valve Choice Matter for Future
  25. How Can We Treat Patients with Concomitant Coronary Artery Disease?
  26. Low Penetration of FFR (1A Class) in Real Practice; Why and How to Overcome?
  27. Case 4. CTO
  28. CTO Revascularization 2022: Guidelines and Concept Change
  29. Physiologic Approach For Non-LM Bifurcation Disease
  30. Unmet Need for FFR in LM PCI
  31. Minimalist TAVI : Achieving Great TAVI Efficiency and Optimal Patient Outcome
  32. 타비 시술을 위한 CT 평가
  33. TAVR for Bicuspid Valve: Practical Tips and Tricks for Optimal Sizing and Positioning
  34. FFR is a Routine Cath Lab Procedure
  35. FFR, It\'s Standard
  36. The Basics of Coronary Physiology Measurement: FFR, iFR and other NHPRs
  37. Updated Imaging/Physiology-Guided PCI Tuning 2021
  38. Under Pressure: Optimal Post-Dilation Strategy
  39. Difficult Wiring, Tips and Tricks
  40. TAVR for Bicuspid AS: Optimal Sizing & Valve Selection
  41. Imaging-guided PSP for Optimizing PCI
  42. How to Treat Tandem Lesion Under Physiology-Guidance
  43. Guide Extension Catheters: Strong Support from Mother-Child Relationship
  44. Post TAVR Coronary Access with Evolut System
  45. Self-Expandable Evolut R & PRO Valve
  46. TAVR for Bicuspid AV: Tips and Tricks
  47. Bifurcation PCI: Contemporary Practical Approach
  48. The Role of Debulking Atherectomy for Calcific In-stent Restenosis
  49. Prognosis of Discordant Lesion Between FFR and Hyperemia Free Indexes
  50. [Case-based Debate: Intracoronary Imaging Modalities for PCI Guidance] IVUS Is Better!
  51. Clinically Relevant PeriProcedural MI: Practical and Clinical Trial Aspect
  52. Case 1: Unexpanded ISR - Challenging and Optimal Treatment
  53. How Do I Implement?: FFR and Various Non-hyperemic Diastolic Index
  54. Current Status of Balloon-Expandable TAVR in Korea
  55. OAC in TAVR: FAILED GALILEO - NOAC Don\'t Work or Other Options?
  56. TAVR for Bicuspid AV: Tips and Tricks
  57. Synergetic Approach for Discordant Lesions Between FFR and Hyperemia Free Indexes
  58. Guide Extension Catheters: A Strong Support from a Parent-Child Relationship
  59. Expert Case Review: Complex PCI for Severe Calcified Coronary Disease
  60. Expert Case Review: Complex Bifurcation PCI
  61. Impact of Renal Function on Stroke or Systemic Embolism Following TAVR
  62. TAVR for Bicuspid Valve: Clinical Outcome and Technical Considerations
  63. TAVR: Bicuspid, Severe Calcium, and Low Lying Left Main
  64. TAVR in Bicuspid Aortic Stenosis with Severe Calcification: Case Reviews and Tips-and-Tricks
  65. How About Integrated Use of Resting Pd/Pa and FFR?
  66. Distal Left Main Bifurcation PCI: Concept Is More Important.
  67. [Case #2: Transcatheter Aortic Valve Implantation in a Patient with Type B Aortic Dissection] Part 2. How Would I Treat?
  68. FFR as the Gold Standard Index!
  69. Five-Year Outcomes of Routine FFR Use in Clinical Practice: Data from ASAN PCI Registry
  70. The Benefit of Complete Revascularization in Complex Coronary Artery Disease
  71. Asian Pacific TAVR Registry
  72. [Taped Case] TAVR with Evolut R
  73. Bicuspid AS: Future Perspectives of TAVR
  74. Integrated Use of FFR and IVUS for LM PCI
  75. Bicuspid TAVR Registry and TRANSIT Trial: TAVI Experience in AMC
  76. Bicuspid and Valve-in-Valve; How Different?
  77. Clinical Outcome of DEFER
  78. Left Main and MVD PCI: Imaging and Functional Guidance
  79. Utility of Intravascular Imaging for Resolving Issues During PCI
  80. Long Lesion and Tandem Lesion
  81. Bicuspid TAVR Registry
  82. AP TAVR Registry
  83. Current Status of TAVR: High/Intermediate and Lower Risk
  84. Clinical Impact of Routine FFR Measurement
  85. Tandem
  86. Prognostic Value of FFR: Insight from IRIS-FFR Registry
  87. Practical Aspect of IMR in AMI and Stable Angina
  88. Elderly Population
  89. LM PCI 2016: Integrated Approach Using IVUS, FFR and New Imaging Modality
  90. [Review in 2015] Physiology
  91. Tandem Lesion Evaluation
  92. Integrated Use of IVUS and FFR in Real Practice
  93. Readmission After PCI or CABG
  94. Left Main
  95. Final Answer RESTORE
  96. Comparative Outcomes of Various DES from IRIS-MAIN Registry and PRECOMBAT Series
  97. Case Presentation 4: Medically Stabilized Type A Aortic Dissection After TAVI
  98. Randomzed Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: Five-Year Outcomes of the PRECOMBAT Study
  99. Preliminary Data from IRIS FFR Registry
  100. Complex Lesions, Left Main, Bifurcations, Tandem, and More
  101. Left Main PCI
  102. Understanding About Visual-Functional Mismatching
  103. TAVI for Bicuspid Valve Stenosis
  104. FFR-guided PCI in Routine Practice: Learn from AMC Experiences
  105. Is There a Generation Gap of DES: Results of PRECOMBAT Study Series
  106. Clinical Implementation of FFR
  107. Case-based Review: Incidence and Treatment of LM ISR
  108. LM & Tandem Lesion
  109. VH IVUS: Native Plaque and Neointima
  110. Clinical Evidence of Neoatherosclerosis: ISR and Late Stent Thrombosis
  111. LM PCI
  112. IRIS-ELEMENT Data Review
  113. Cross and Perfect: 2013 Update
  114. Anatomical - Functional Stenosis: How Much Discordant?
  115. Case Presentation: Functional Angioplasty
  116. Impact of Functional Angioplasty on Clinical Outcomes of PCI
  117. Novice's Trial of Complex LM PCI
  118. New-generation DES for Long Lesions: From a Large-scale Cohort Regis
  119. FFR Utilization in LM PCI
  120. Promus Element Clinical Program in Asan Medical Center
  121. FFR-guided PCI in Tandem Lesion
  122. Two Cases with Coronary Thromboembolism
  123. Does the Timing of IABP Matter?
Conference Slides
Category